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A B S T R A C T
Type-II NADH:quinone oxidoreductases (NDH-2s) are membrane proteins involved in respiratory chains and the
only enzymes with NADH:quinone oxidoreductase activity expressed in Staphylococcus aureus (S. aureus), one
of the most common causes of clinical infections. NDH-2s are members of the two-Dinucleotide Binding Domains
Flavoprotein (tDBDF) superfamily, having a ﬂavin adenine dinucleotide, FAD, as prosthetic group and NAD(P)H
as substrate. The establishment of a Charge-Transfer Complex (CTC) between the isoalloxazine ring of the re-
duced ﬂavin and the nicotinamide ring of NAD+ in NDH-2 was described, and in this work we explored its role
in the kinetic mechanism using diﬀerent electron donors and electron acceptors. We observed that CTC slows
down the rate of the second half reaction (quinone reduction) and determines the eﬀect of HQNO, an inhibitor.
Also, protonation equilibrium simulations clearly indicate that the protonation probability of an important re-
sidue for proton transfer to the active site (D302) is inﬂuenced by the presence of the CTC. We propose that CTC
is critical for the overall mechanism of NDH-2 and possibly relevant to keep a low quinol/quinone ratio and
avoid excessive ROS production in vivo.
1. Introduction
Flavoproteins account for ~1% of proteins and are highly versatile
enzymes, which perform many diverse reactions [1,2]. In many cases a
charge-transfer complex (CTC) is formed whose role remains elusive
[3–10]. In this way, we used type II NADH: quinone oxidoreductases
(NDH-2s) to investigate how the ﬂavin reactivity is controlled and
modulated by the presence of the CTC.
NDH-2s are membrane proteins involved in respiratory chains and
in the metabolic regeneration of NAD+. They are recognized as suitable
targets for novel antimicrobial therapies considering they are the only
enzymes with NADH:quinone oxidoreductase activity present in many
pathogenic organisms, both bacteria and protozoa [11]. These enzymes
belong to the two-Dinucleotide Binding Domains Flavoprotein (tDBDF)
superfamily, which share two structurally related Rossmann fold do-
mains for the binding of dinucleotides (FAD and NADH) [12]. Struc-
tural studies on NDH-2 have long contributed to the understanding of
this enzyme, solving several controversies including the number and
location of the substrate binding sites [5,13–15]. Also the possible role
of NDH-2 as a drug target as been thoroughly explored [16–18].
Nevertheless, functional information is still not fully congruent and the
reaction mechanism of NDH-2 remains unknown.
Previous pre-steady state kinetic studies of NDH-2 from S. aureus,
reported the presence of a CTC formed between NAD+ and the reduced
ﬂavin, which is dissociated upon oxidation by the quinone (2,3-
Dimethyl-1,4-naphthoquinone, DMN) [5], indicating the involvement
of a ternary complex in the catalytic mechanism of NDH-2. These stu-
dies also showed that FAD reduction by NADH was an order of mag-
nitude faster than FADH2 oxidation by the quinone (180 ± 30 s−1 vs
5.0 ± 0.5 s−1, respectively) and 2-n-Heptyl-4-hydroxyquinoline N-
oxide (HQNO) inhibition only aﬀected the kinetically limiting second
half-reaction of the enzymatic turnover (0.08 ± 0.02 s). Intriguingly,
NDH-2 from Caldalkalibacillus thermarum was also reported to establish
a CTC upon reduction with NADH, but with similar FAD reduction and
oxidation half-reaction rates (200 s−1) [4]. In this case a diﬀerent
quinone analogue, menadione, was used, which has one less methyl
group and a higher reduction potential then DMN (0 vs −90mV)
[19–21].
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Marreiros et al. [22], recently proposed the ﬁrst catalytic me-
chanism for NDH-2 family. In this study, which contemplates CTC
formation coincidentally with NADH binding, aspartate 302 (D302),
present in the vicinity of FAD, was observed to be totally conserved
(100%), even among other members of the tDBDF superfamily. The
authors suggested the involvement of D302 in the catalytic mechanism
of NDH-2 as a putative proton donor in FAD reduction or proton ac-
ceptor in FADH2 oxidation. The authors have also observed the pre-
sence of a conserved glutamate residue (E172) in the proximity of the
NADH binding site, and proposed it as part of a proton conductive
pathway. This residue was later proved to be further involved in the
stabilization of the NADH binding and CTC establishment [23].
In the present work, we aimed at unraveling the role of the CTC in
the reaction mechanism of NDH-2 and understanding its inﬂuence on
ﬂavin reactivity, in general.
2. Materials and methods
2.1. Enzyme expression and puriﬁcation
E. coli Rosetta 2 (DE3) pLysS cells were transformed with the
plasmid pET-28a(+) (Novagen) carrying the gene SAOUHSC_00878,
coding for NDH-2 from S. aureus NCTC8325. Protein expression and
puriﬁcation were conducted as described previously [24]. Protein
concentration was determined by the Pierce™ BCA protein assay kit or
using the FAD extinction coeﬃcient of 11.3 M−1 cm−1 [25].
2.2. Kinetic studies
Pre-steady state kinetic experiments were performed in a TgK
Scientiﬁc stopped-ﬂow instrument placed inside an anaerobic chamber
and equipped with a diode array detector, capable of acquiring spectra
in the wavelength range of 350–700 nm at a rate of 1 spectrum per
1.5 ms. The temperature of the drive syringes and mixing chamber was
maintained at 15 °C and the pH was controlled with 100mM potassium
phosphate buﬀer pH 7.0, 250mM NaCl. All solutions were prepared
inside the anaerobic chamber with degassed water. The reductive re-
action was monitored after mixing oxidized NDH-2 with NADH or so-
dium dithionite, Na2S2O4 (1:1 ratio). Reduced NDH-2 was mixed with
quinone or O2 (1:2 ratio) to study the oxidative reaction. Complete
turnovers were monitored using two equivalents of NADH/ sodium
dithionite and quinone. Similar assays were performed in the presence
of the inhibitor, HQNO.
2.3. Simulation of equilibrium protonation states
pH titration curves were calculated for all ionizable amino acid
residues, including D302, of NDH-2 from S. aureus (PDB: 5NA1), based
on the thermodynamics of proton binding as described before in detail
[26,27]. These methodologies use a combination of Poisson-Boltzmann
(PB) calculations, performed with the program MEAD (version 2.2.9)
[28–30], and Metropolis Monte Carlo (MC) simulations, using the
program PETIT (version 1.5) [31]. Here, two systems were simulated:
the fully reduced state FADH2 similar to that obtained with dithionite,
and the fully reduced protein with NAD+ forming the charge transfer
complex in the catalytic site, FADH2-NAD+. The position of the NAD+
was inferred upon ﬁtting to the structure of the S. cerevisiae enzyme
(PDB entry: 4G73).
3. Results and discussion
3.1. The presence of a Charge-transfer Complex
In the oxidized form, NDH-2 presents an absorption spectrum with
maxima at 375 and 450 nm and a shoulder close to 475 nm, typical of
ﬂavoproteins (Fig. 1). Upon reduction with NADH, the absorption at
375–450 nm decreases and a broad absorption band at the 650–800 nm
region appears. This band is considered to be originated by the estab-
lishment of a CTC resulting from a π-π interaction between the parallel
stacked isoalloxazine and nicotinamide rings of reduced FAD and
NAD+ respectively. The enzyme was also reduced with sodium di-
thionite and in this case the decrease in absorption at 375–450 nm was
also observed, but the band resulting from the establishment of the CTC
was not detected (Fig. 1). A CTC could also be observed by adding
NAD+ to the dithionite-reduced NDH-2 [5], meaning that the CTC was
formed only in the presence of the NAD+/FADH2, independently of the
reducing agent.
3.2. The Charge-Transfer Complex is a limiting factor in protein oxidation
In order to investigate the role of the charge-transfer complex on the
catalytic mechanism of NDH-2, we compared the oxidation of NDH-2
when reduced by NADH, which establishes a CTC, to that of the enzyme
reduced by dithionite, which does not establish a CTC. Upon addition of
quinone (in a 1:1 ratio) to NDH-2 previously reduced with NADH,
spectral changes showed an increase in the absorbance peak at 450 nm
and the disappearance of the broad band at 650–800 nm. The rate
constant obtained for this second half-reaction was equal to
5.0 ± 0.5 s−1 (Fig. 2A) [5]. The dithionite-reduced NDH-2 was mixed
with DMN in a 1:1 ratio (Fig. 2B) and a rate constant equal to
196 ± 15 s−1 was measured. This reaction was approximately 40
times faster than the oxidation of the NADH-reduced NDH-2 (Fig. 2A)
[5] and interestingly similar to the rate constant for the reduction of the
protein by NADH. In order to conﬁrm whether the diﬀerence observed
in the oxidation reaction of FAD was due to the presence of the CTC we
incubated the dithionite-reduced enzyme with NAD+ and monitored its
reaction with DMN (all the components were in a 1:1 ratio) (Fig. 2C).
The rate constant obtained was 11.4 ± 2.2 s−1, which is comparable to
that observed for the oxidation of the NADH-reduced enzyme by the
quinone. These data indicate the presence of the CTC is a limiting factor
in protein oxidation.
3.3. The Charge-Transfer Complex decreases the oxidation rate
independently of the oxidant
We also investigated whether the observed eﬀect of the CTC on the
oxidation reaction was dependent on the quinone, i.e., of the oxidant.
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Fig. 1. UV–visible absorption spectra of NDH-2 as puriﬁed (black solid line), reduced
with NADH (blue solid line) or reduced with sodium dithionite (blue dashed line). The
inserted ﬁgure expands absorption spectra in the 600–800 region (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of
this article.).
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For this we used oxygen, O2, as the electron acceptor. In the ﬁrst ex-
periment 10 µM NDH-2 was reduced with a stoichiometric amount of
NADH and then the reduced NDH-2 was mixed with buﬀer containing
24 µM O2 in approximately 1:2 protein:O2 ratio (Fig. 3A).
The oxidation of the protein by oxygen was very slow, with a rate
constant of 0.0044 ± 0.0007 s−1. In this experiment we could also
observe a decrease in absorbance at 650–800 nm due to the dissociation
of the CTC (Fig. 3A). In a second experiment, we reduced the protein
with sodium dithionite (1:1 ratio) and monitored its reaction with O2
(1:2 ratio). The rate constant obtained was 0.76 ± 0.2 s−1 higher than
that measured for the oxidation of the NADH-reduced NDH-2. Also, as
expected, the absorbance in the 650–800 nm region did not change, as a
CTC was not present in the reduced enzyme to begin with. These results
reinforce the idea that the presence of the CTC determines the oxidation
rate of the protein.
3.4. The presence of the CTC determines the inhibitory eﬀect of HQNO
We previously showed that HQNO, a quinone derivative, acts as an
inhibitor of S. aureus´NDH-2 activity with an apparent Ki value of
6.8 ± 0.4 µM. It was also demonstrated that the oxidation of the en-
zyme by DMN is strongly impaired in the presence of HQNO (unlike the
ﬁrst half reaction which is not aﬀected) and that the binding sites for
HQNO and the quinone are superimposed or very close [5].
Here we tested whether the presence of the CTC, which also inﬂu-
ences the second half reaction, would alter the eﬀect of the inhibitor.
For this we compared the eﬀect of HQNO (10 µM) on the rate of protein
oxidation by DMN (10 µM), in the case of NADH or dithionite reduced
protein (10 µM). The rate of oxidation of dithionite-reduced protein by
DMN in the presence of HQNO was 179 ± 12 s−1, a value similar to
that obtained in the absence of the inhibitor, which suggests that in the
absence of CTC the HQNO has no eﬀect (Fig. 4B). This is completely
diﬀerent from the result obtained previously, where the oxidation of
NDH-2 by DMN, after its reduction by NADH, was slowed-down by a
factor of 50 (to 0.08 ± 0.02 s−1) in the presence of HQNO (Fig. 4A)
[5]. Again, in order to conﬁrm whether the diﬀerence observed in the
eﬀect of HQNO was due to the presence of the CTC we incubated the
dithionite-reduced enzyme with NAD+ and monitored its reaction with
DMN in the presence of the inhibitor. In this situation we observed the
Fig. 2. Time-resolved oxidation by DMN of (A) NADH-reduced NDH-2 (1:1, protein:DMN
ratio), (B) sodium dithionite-reduced NDH-2 (1:1, protein:DMN ratio) and (C) sodium
dithionite-reduced NDH-2 in the presence of NAD+ (1:1:1, protein: DMN:NAD+ ratio),
monitored at 450 nm (red dots) and at 670 nm (blue dots) (For interpretation of the re-
ferences to color in this ﬁgure legend, the reader is referred to the web version of this
article.).
Fig. 3. Time-resolved oxidation by O2 of (A) NADH-reduced NDH-2 (1:2, NDH-2: O2
ratio) and (B) dithionite-reduced NDH-2 (1:2, NDH-2: O2 ratio) monitored at 450 nm (red
dots) and at 670 nm (blue dots) (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.).
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protein oxidation was also very slow, with a rate constant of
0.1 ± 0.0006 s−1, a value that is similar to that obtained when the
enzyme was reduced with NADH and then oxidized by DMN in the
presence of HQNO (Fig. 4C).
3.5. The presence of the CTC inﬂuences the protonation probability of D302
We performed protonation equilibrium simulations for all the io-
nizable amino acid residues of NDH-2 from S. aureus. Two diﬀerent
systems were simulated: the fully reduced state (FADH2), similar to that
obtained with dithionite, and the fully reduced protein with NAD+
(FADH2-NAD+) in which the CTC is present.
Our protonation equilibrium simulations for NDH-2 from S. aureus
indicate that the proton occupancy probability of the majority of the
ionizable amino acid residues was not signiﬁcantly altered by the pre-
sence of the CTC. D302 was the exception, for which our simulations
clearly showed that its proton occupancy probability in the reduced
enzyme is inﬂuenced by the presence of the CTC (Fig. 5).
According to the proposed catalytic mechanism of Marreiros et al.
[22], upon binding of NADH, FAD is reduced through hydride transfer
to the N5 of the FAD isoalloxazine ring. The second proton needed for
the full protonation of the reduced FAD is suggested to be provided by
rearrangement of the hydrogen bond network around N1 in which a
strictly conserved D302 is present. The high conservation of D302 is
extended to several families of the tDBDF superfamily, further sug-
gesting its importance in the oxidation/reduction processes of FAD.
Upon quinone binding, FADH2 transfers two electrons to the quinone,
which is provided of two protons by the previously observed putative
proton pathways [22]. After FADH2 oxidation, the ﬂavin returns to its
original conformation, leading to the release of the protons at N5 and
N1. This proton at N1 undergoes the reverse process that restores the
initial hydrogen bonding network around D302.
We observed that the proton occupancy probability curve of D302
in the case of FADH2 (in the absence of CTC) is diﬀerent from that
obtained in the case of FADH2-NAD+ (in the presence of the CTC). The
curve in the presence of the CTC is shifted to higher pH values com-
paring to that obtained in its absence. This means that at pH 7 it is more
diﬃcult to oxidize FADH2-NAD+, because in this state D302 is almost
100% protonated and therefore unable to receive protons. In the ab-
sence of NAD+ at pH 7, D302 is expected to have a much lower proton
occupancy, allowing proton transfer from the active site and faster
oxidation of the FADH2.
Therefore, the diﬀerence observed for the proton occupancy prob-
ability of D302 of the reduced protein in the presence and absence of
the CTC can contribute to explain the diﬀerent oxidation rates observed
by pre-steady state kinetics.
4. Conclusions
The establishment of a CTC between ﬂavoproteins and NADH is well
documented, and has been observed for many enzymes catalyzing dif-
ferent reactions [32]. Likewise, in previous work we described the
formation of a CTC in the reduction of NDH-2 with NADH, which dis-
appears upon oxidation by the quinone. In this work, we describe, for
the ﬁrst time, that the presence of the CTC controls the rate of the
second half reaction and inﬂuences the eﬀect of the inhibitor HQNO.
We show that the oxidation reaction is limited by the presence of
the CTC because the dithionite-reduced NDH-2 oxidation rate is 40
Fig. 4. Time-resolved oxidation by DMN of (A) NADH- reduced NDH-2 in the presence of
HQNO (1:1:5, NDH-2:DMN:HQNO ratio), (B) dithionite- reduced NDH-2 in the presence
of HQNO (1:1:5, NDH-2:DMN:HQNO ratio) and (C) dithionite- reduced NDH-2 in the
presence of HQNO and NAD+ (1:1:5:1, NDH-2:DMN:HQNO:NAD+ ratio).
Fig. 5. Proton equilibrium occupancy probability curves for D302 in two reduced con-
ditions: FADH2 (in red) and FADH2-NAD+ (in green) (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this article.).
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times faster than the oxidation rate of the NADH-reduced NDH-2. The
eﬀect of the presence of the CTC is also observed when oxygen is the
electron acceptor, revealing that the presence of the CTC decreases the
rate of the second half reaction, independently of the oxidant. This set
of results, summarized in Table 1, can be partially explained by the
protonation equilibrium simulations which revealed that the protona-
tion of D302 in the reduced enzyme is strongly inﬂuenced by the pre-
sence of NAD+: protonated D302 populations at pH 7, which decreases
from almost 100% in the presence of NAD+ to only 20% in its absence.
When testing HQNO, we noticed it decreases the rate of oxidation of
the enzyme when the CTC is observed, having no eﬀect when the en-
zyme is reduced with dithionite. In this case one could hypothesize that
DMN could accept electrons from the unoccupied site of NADH.
However we can rule out this hypothesis based on our previous data
obtained by STD-NMR and Fluorescence spectroscopies, which showed
that NADH and DMN interact with the protein at two diﬀerent sites,
without interfering with each other. We also observed that HQNO only
aﬀects the binding of DMN [5] discarding the possibility of HQNO
binding to the NADH site when the nucleotide is absent. Thus our
present result indicates that the presence of the CTC produces con-
formational changes at the HQNO and quinone binding pocket(s),
which may be favorable for the binding of HQNO and disadvantageous
for the binding of the quinone. In this way, HQNO acted as a probe
reﬂecting conformational changes at the quinone binding site. The
hypothesis that the establishment of the CTC is disadvantageous for the
binding of the quinone can also contribute to explain the observed
diﬀerence in the rates of the second half reaction in the presence or
absence of the CTC, in addition to its inﬂuence on the protonation
probability of D302.
We can conclude that the presence of the CTC slows down the
second half reaction. The physiological relevance of this eﬀect is un-
known, however we hypothesize it may contribute to keep a low
quinol/quinone ratio and thus avoid the production of radical oxygen
species by unspeciﬁc oxidation of quinol. We believe that our hypoth-
esis for the physiological relevance of the molecular control of the en-
zymatic mechanism will foster further discussion and pave the way for
in vivo studies.
Acknowledgments
FVS and FMS are recipients of fellowships by Fundação para a
Ciência e a Tecnologia (PD/BD/113985/2015, PD/BD/128213/2016,
respectively (within the scope of the PhD program Molecular
Biosciences PD/00133/2012)). The work was funded by Fundação para
a Ciência e a Tecnologia (IF/01507/2015 to MMP). This work was also
supported by Project LISBOA-01-0145-FEDER-007660 (Microbiologia
Molecular, Estrutural e Celular) funded by FEDER funds through
COMPETE2020 - Programa Operacional Competitividade e
Internacionalização (POCI) and by national funds through FCT -
Fundação para a Ciência e a Tecnologia and by national funds through
FCT - Fundação para a Ciência e a Tecnologia and by UID/MULTI/
04046/2013 centre grant from FCT, Portugal (to BioISI).
References
[1] V. Piano, B.A. Palfey, A. Mattevi, Flavins as covalent catalysts: new mechanisms
emerge, Trends Biochem. Sci. 42 (2017) 457–469, http://dx.doi.org/10.1016/j.
tibs.2017.02.005.
[2] W.P. Dijkman, G. De Gonzalo, A. Mattevi, M.W. Fraaije, Flavoprotein oxidases:
classiﬁcation and applications, Appl. Microbiol. Biotechnol. 97 (2013) 5177–5188,
http://dx.doi.org/10.1007/s00253-013-4925-7.
[3] A.P. Landry, D.P. Ballou, R. Banerjee, H2S oxidation by nanodisc-embedded human
sulﬁde quinone oxidoreductase, J. Biol. Chem. 292 (2017) 11641–11649, http://dx.
doi.org/10.1074/jbc.M117.788547.
[4] J.N. Blaza, H.R. Bridges, D. Aragão, E.A. Dunn, A. Heikal, G.M. Cook, Y. Nakatani,
J. Hirst, The mechanism of catalysis by type-II NADH:quinone oxidoreductases, Sci.
Rep. 7 (2017), http://dx.doi.org/10.1038/srep40165.
[5] F.V. Sena, A.P. Batista, T. Catarino, J.A. Brito, M. Archer, M. Viertler, T. Madl,
E.J. Cabrita, M.M. Pereira, Type-II NADH: quinone oxidoreductase from
Staphylococcus aureus has two distinct binding sites and is rate limited by quinone
reduction, Mol. Microbiol. 98 (2015) 272–288, http://dx.doi.org/10.1111/mmi.
13120.
[6] M.M. Elguindy, E. Nakamaru-Ogiso, Apoptosis-inducing factor (AIF) and its family
member protein, AMID, are rotenone-sensitive NADH:ubiquinone oxidoreductases
(NDH-2), J. Biol. Chem. 290 (2015) 20815–20826, http://dx.doi.org/10.1074/jbc.
M115.641498.
[7] A.S. Abramovitz, V. Massey, Interaction of phenols with old yellow enzyme.
Physical evidence for charge transfer complexes, J. Biol. Chem. 251 (1976)
5327–5336 (doi:8461).
[8] B. Gao, H.R. Ellis, Mechanism of ﬂavin reduction in the alkanesulfonate mono-
oxygenase system, Biochim. Biophys. Acta - Proteins Proteom. 1774 (2007)
359–367, http://dx.doi.org/10.1016/j.bbapap.2006.12.006.
[9] O. Dmitrenko, C. Thorpe, R.D. Bach, Eﬀect of a charge-transfer interaction on the
catalytic activity of Acyl-CoA dehydrogenase: a theoretical study of the role of
oxidized ﬂavin, J. Phys. Chem. B 107 (2003) 13229–13236, http://dx.doi.org/10.
1021/jp0348631.
[10] H. Li, J. Jamal, G. Chreiﬁ, V. Venkatesh, H. Abou-Ziab, T.L. Poulos, Dissecting the
kinetics of the NADP+-FADH2 charge transfer complex and ﬂavin semiquinones in
neuronal nitric oxide synthase, J. Inorg. Biochem. 124 (2013) 1–10, http://dx.doi.
org/10.1016/j.jinorgbio.2013.03.008.
[11] G.M. Cook, C. Greening, K. Hards, M. Berney, Energetics of pathogenic bacteria and
opportunities for drug development, Adv. Microb. Physiol. 65 (2014) 1–62, http://
dx.doi.org/10.1016/bs.ampbs.2014.08.001.
[12] S. Ojha, E.C. Meng, P.C. Babbitt, Evolution of function in the “two dinucleotide
binding domains” ﬂavoproteins, PLoS Comput. Biol. 3 (2007) 1268–1280, http://
dx.doi.org/10.1371/journal.pcbi.0030121.
[13] Y. Yang, Y. Yu, X. Li, J. Li, Y. Wu, J. Yu, J. Ge, Z. Huang, L. Jiang, Y. Rao, M. Yang,
Target elucidation by cocrystal structures of nadh-ubiquinone oxidoreductase of
Plasmodium falciparum (PfNDH2) with small molecule to eliminate drug-resistant
malaria, J. Med. Chem. 60 (2017) 1994–2005, http://dx.doi.org/10.1021/acs.
jmedchem.6b01733.
[14] A. Heikal, Y. Nakatani, E. Dunn, M.R. Weimar, C.L. Day, E.N. Baker, J.S. Lott,
L.A. Sazanov, G.M. Cook, Structure of the bacterial type II NADH dehydrogenase: a
monotopic membrane protein with an essential role in energy generation, Mol.
Microbiol. 91 (2014) 950–964, http://dx.doi.org/10.1111/mmi.12507.
[15] Y. Feng, W. Li, J. Li, J. Wang, J. Ge, D. Xu, Y. Liu, K. Wu, Q. Zeng, J.W. Wu, C. Tian,
B. Zhou, M. Yang, Structural insight into the type-II mitochondrial NADH dehy-
drogenases, Nature 491 (2012) 478–482, http://dx.doi.org/10.1038/nature11541.
[16] P.S. Shirude, B. Paul, N. Roy Choudhury, C. Kedari, B. Bandodkar, B.G. Ugarkar,
Quinolinyl pyrimidines: potent inhibitors of NDH-2 as a novel class of anti-TB
agents, ACS Med. Chem. Lett. 3 (2012) 736–740, http://dx.doi.org/10.1021/
ml300134b.
[17] T. Yano, L. Lin-Sheng, E. Weinstein, J.S. Teh, H. Rubin, Steady-state kinetics and
inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis
Type-II NADH-menaquinone oxidoreductase (NDH-2), J. Biol. Chem. 281 (2006)
11456–11463, http://dx.doi.org/10.1074/jbc.M508844200.
[18] S. Sellamuthu, M. Singh, A. Kumar, S.K. Singh, Type-II NADH Dehydrogenase
(NDH-2): a promising therapeutic target for antitubercular and antibacterial drug
discovery, Expert Opin. Ther. Targets 21 (2017) 559–570, http://dx.doi.org/10.
1080/14728222.2017.1327577.
[19] R.K.K. THAUER, K. Jungermann, K. DECKER, Energy conservation in chemotrophic
anaerobic bacteria, Microbiol. Mol. Biol. Rev. 41 (1977) 100–180.
[20] J.B. Conant, L.F. Fieser, Reduction potentials of quinones. II. The potentials of
certain derivatives of benzoquinone, naphthoquinone and anthraquinone, J. Am.
Chem. Soc. 46 (1924) 1858–1881, http://dx.doi.org/10.1021/ja01673a014.
[21] H.R. Nasiri, R. Panisch, M.G. Madej, J.W. Bats, C.R.D. Lancaster, H. Schwalbe, The
correlation of cathodic peak potentials of vitamin K3 derivatives and their calcu-
lated electron aﬃnities. The role of hydrogen bonding and conformational changes,
Biochim. Biophys. Acta - Bioenerg. 1787 (2009) 601–608, http://dx.doi.org/10.
1016/j.bbabio.2009.02.013.
[22] B.C. Marreiros, F.V. Sena, F.M. Sousa, A.S.F. Oliveira, C.M. Soares, A.P. Batista,
M.M. Pereira, Structural and Functional insights into the catalytic mechanism of the
Type II NADH:quinone oxidoreductase family, Sci. Rep. 7 (2017), http://dx.doi.
org/10.1038/srep42303.
[23] F.M. Sousa, F.V. Sena, A.P. Batista, D. Athayde, J.A. Brito, M. Archer,
A.S.F. Oliveira, C.M. Soares, T. Catarino, M.M. Pereira, The key role of glutamate
172 in the mechanism of type II NADH:quinone oxidoreductase of Staphylococcus
aureus, Biochim. Biophys. Acta - Bioenerg. 1858 (2017) 823–832, http://dx.doi.
org/10.1016/j.bbabio.2017.08.002.
[24] A.L.ú Cia Rosário, F.V. Sena, A.P. Batista, T.F. Oliveira, D. Athayde, M.M. Pereira,
J.A. Brito, M. Archer, Expression, puriﬁcation, crystallization and preliminary X-ray
diﬀraction analysis of a type II NADH:quinone oxidoreductase from the human
Table 1
Summary of kinetic rate constant values for the second half-reaction - ﬂavin oxidation.
Oxidizing substrate / inhibitor
Reducing substrate DMN DMN+HQNO O2
NADH 5.0±0.5 0.08± 0.02 0.0044±0.0007
Dith + NAD+ 11.4± 2.2 0.1±0.0006 –
Dith 196±15 179±12 0.76± 0.2
F.V. Sena et al. Redox Biology 16 (2018) 209–214
213
pathogen Staphylococcus aureus, Acta Cryst. 71 (2015) 477–482, http://dx.doi.
org/10.1107/S2053230×15005178.
[25] A. Aliverti, B. Curti, M.A. Vanoni, Identifying and Quantitating FAD and FMN in
Simple and in Iron-Sulfur-Containing Flavoproteins, in: S.K. Chapman, G.A. Reid
(Eds.), Flavoprotein Protoc. HUMANA PRESS, 1999, pp. 9–23.
[26] V.H. Teixeira, C.M. Soares, A.M. Baptista, Studies of the reduction and protonation
behavior of tetraheme cytochromes using atomic detail, J. Biol. Inorg. Chem. 7
(2002) 200–216, http://dx.doi.org/10.1007/s007750100287.
[27] A.M. Baptista, C.M. Soares, Some theoretical and computational aspects of the in-
clusion of proton isomerism in the protonation equilibrium of proteins, J. Phys.
Chem. B 105 (2001) 293–309, http://dx.doi.org/10.1021/jp002763e.
[28] D. Bashford, K. Gerwert, Electrostatic calculations of the pKa values of ionizable
groups in bacteriorhodopsin, J. Mol. Biol. 224 (1992) 473–486, http://dx.doi.org/
10.1016/0022-2836(92)91009-E.
[29] D. Bashford, M. Karplus, pKa's of ionizable groups in proteins: atomic detail from a
continuum electrostatic model, Biochemistry 29 (1990) 10219–10225, http://dx.
doi.org/10.1021/bi00496a010.
[30] D. Bashford, An object-oriented programming suite for electrostatic eﬀects in bio-
logical molecules: An experience report on the MEAD project, in: Lect. Notes
Comput. Sci. (Including Subser. Lect. Notes Artif. Intell. Lect. Notes Bioinformatics):
1997: pp. 233–240. https://dx.doi.org/10.1007/3-540-63827-X_66.
[31] T. Sakurai, H. Hosoya, Charge-transfer complexes of nicotinamide-adenine dinu-
cleotide analogues and ﬂavin mononucleotide, Biochim. Biophys. Acta - Biophys.
Incl. Photosynth. 112 (1966) 459–468, http://dx.doi.org/10.1016/0926-6585(66)
90248-2.
[32] H. Sakurai, T. Hosoya, Charge-transfer complexes of nicotinamide-adenine dinu-
cleotide analogues and ﬂavin mononucleotide, Acta Biophys. 112 (1965) 459–468.
F.V. Sena et al. Redox Biology 16 (2018) 209–214
214
